Durham, NC, United States of America

Mir A Hashim

This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2005.


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mir A Hashim: Innovator in Pharmaceutical Formulations

Introduction

Mir A Hashim is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of histamine releasers. His innovative work has led to the development of methods that enhance the efficacy and safety of pharmaceutical products.

Latest Patents

Mir A Hashim holds 1 patent for his invention titled "Methods for preparing pharmaceutical formulations." This invention relates to pharmaceutical formulations and methods for preparing formulations of histamine releasers. The patent provides methods for determining the concentration of physiologically acceptable excipients for use in these formulations. Additionally, it offers methods for suppressing pharmaceutically-induced histamine release by administering the formulations to an animal. A kit useful for preparing these pharmaceutical formulations is also included in the patent.

Career Highlights

Mir A Hashim is associated with SmithKline Beecham Corporation, where he has been instrumental in advancing pharmaceutical research and development. His work has contributed to the creation of safer and more effective medications.

Collaborations

Some of his notable coworkers include Alison G Floyd and Peiyuan Lin, who have collaborated with him on various projects within the pharmaceutical domain.

Conclusion

Mir A Hashim's contributions to pharmaceutical formulations demonstrate his commitment to innovation in the healthcare industry. His work continues to impact the development of effective treatments for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…